125 related articles for article (PubMed ID: 6169657)
1. Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity.
Camiolo SM; Markus G; Evers JL; Hobika GH; DePasquale JL; Beckley S; Grimaldi JP
Int J Cancer; 1981 Feb; 27(2):191-8. PubMed ID: 6169657
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues.
Camiolo SM; Markus G; Englander LS; Siuta MR; Hobika GH; Kohga S
Cancer Res; 1984 Jan; 44(1):311-8. PubMed ID: 6197164
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
Camiolo SM; Greco WR
Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator activity in prostatic cancer.
Köller A; Kirchheimer J; Pflüger H; Binder BR
Eur Urol; 1984; 10(6):389-94. PubMed ID: 6085049
[TBL] [Abstract][Full Text] [Related]
5. [Tissue plasminogen activator activity in early prostatic cancer and in bone metastases of prostatic cancer].
Pflüger H; Kirchheimer J; Ritschl P; Köller A; Hienert G; Binder BR
Wien Klin Wochenschr; 1984 Sep; 96(17):658-61. PubMed ID: 6083673
[TBL] [Abstract][Full Text] [Related]
6. Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Moritz TE; Rousseau SM; Stump DC
Cancer; 1991 Mar; 67(5):1377-83. PubMed ID: 1703919
[TBL] [Abstract][Full Text] [Related]
7. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
Wijngaards G
Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator activity in bone metastases of prostatic carcinomas as compared to primary tumors.
Kirchheimer JC; Pflüger H; Ritschl P; Hienert G; Binder BR
Invasion Metastasis; 1985; 5(6):344-55. PubMed ID: 4066206
[TBL] [Abstract][Full Text] [Related]
9. Localization and immunological characterization of plasminogen activators in human prostate tissue.
Kirchheimer J; Binder BR
Haemostasis; 1983; 13(6):358-62. PubMed ID: 6199265
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activators in human malignant melanoma.
Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C
J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.
Kirchheimer J; Köller A; Binder BR
Biochim Biophys Acta; 1984 Feb; 797(2):256-65. PubMed ID: 6199043
[TBL] [Abstract][Full Text] [Related]
12. Expression of urokinase plasminogen activator, its receptor and type-1 inhibitor in malignant and benign prostate tissue.
Usher PA; Thomsen OF; Iversen P; Johnsen M; Brünner N; Høyer-Hansen G; Andreasen P; Danø K; Nielsen BS
Int J Cancer; 2005 Mar; 113(6):870-80. PubMed ID: 15515049
[TBL] [Abstract][Full Text] [Related]
13. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
[TBL] [Abstract][Full Text] [Related]
14. Identification of a plasminogen activator derived from nasopharyngeal carcinoma.
Kosugi T; Huang GW; Nakamura M; Koja S; Nong HT
Eur Arch Otorhinolaryngol; 1990; 247(6):374-8. PubMed ID: 2126177
[TBL] [Abstract][Full Text] [Related]
15. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
Rijken DC; Wijngaards G; Welbergen J
J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
[TBL] [Abstract][Full Text] [Related]
16. A sensitive and specific assay for plasminogen activators.
Smith DS; Harmon J; Owen WG
Thromb Res; 1985 Feb; 37(4):533-41. PubMed ID: 4039078
[TBL] [Abstract][Full Text] [Related]
17. A highly sensitive chromogenic microtiter plate assay for plasminogen activators which quantitatively discriminates between the urokinase and tissue-type activators.
Karlan BY; Clark AS; Littlefield BA
Biochem Biophys Res Commun; 1987 Jan; 142(1):147-54. PubMed ID: 3101684
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.
Sier CF; Verspaget HW; Griffioen G; Ganesh S; Vloedgraven HJ; Lamers CB
Gut; 1993 Jan; 34(1):80-5. PubMed ID: 8432457
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activators and inhibitors are transcribed during early macaque implantation.
Feng Q; Liu K; Liu YX; Byrne S; Ockleford CD
Placenta; 2001; 22(2-3):186-99. PubMed ID: 11170823
[TBL] [Abstract][Full Text] [Related]
20. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
